| |
| |
|
| Insider
Information: |
Deschatelets Pascal |
| Relationship: |
Chief Scientific Officer |
| City: |
Crestwood |
| State: |
KY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,140,483 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$47,558,141 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,140,483 |
|
|
| Total
Value |
$47,558,141 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-5.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -164.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Apellis Pharmaceuticals Inc |
APLS |
Chief Scientific Officer |
2024-05-20 |
1,140,483 |
2018-05-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
80 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
• • – |
2022-12-08 |
4 |
OE |
$2.67 |
$49,395 |
D/D |
18,500 |
982,280 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
• • – |
2023-01-09 |
4 |
OE |
$2.67 |
$49,395 |
D/D |
18,500 |
995,780 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
• • – |
2023-02-08 |
4 |
OE |
$2.67 |
$49,395 |
D/D |
18,500 |
1,018,756 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
• • – |
2023-03-08 |
4 |
OE |
$2.67 |
$49,395 |
D/D |
18,500 |
1,032,813 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
• • – |
2023-04-10 |
4 |
OE |
$2.67 |
$49,395 |
D/D |
18,500 |
1,039,313 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
• • – |
2023-05-08 |
4 |
OE |
$2.67 |
$49,395 |
D/D |
18,500 |
1,045,813 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
• • – |
2023-06-08 |
4 |
OE |
$2.67 |
$49,395 |
D/D |
18,500 |
1,052,313 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
• • – |
2023-07-10 |
4 |
OE |
$2.67 |
$49,395 |
D/D |
18,500 |
1,058,813 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
• • – |
2023-08-08 |
4 |
OE |
$2.67 |
$49,395 |
D/D |
18,500 |
1,065,313 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
• • – |
2023-09-08 |
4 |
OE |
$2.67 |
$49,395 |
D/D |
18,500 |
1,071,813 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
• • – |
2023-10-09 |
4 |
OE |
$2.67 |
$49,395 |
D/D |
18,500 |
1,078,313 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
• • – |
2022-02-10 |
4 |
D |
$47.12 |
$49,806 |
D/D |
(1,057) |
893,650 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
• • – |
2024-01-29 |
4 |
S |
$64.14 |
$56,057 |
D/D |
(874) |
1,117,131 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
• • – |
2023-02-10 |
4 |
D |
$51.21 |
$58,072 |
D/D |
(1,134) |
1,005,622 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
• – – |
2023-02-21 |
4 |
D |
$58.50 |
$69,908 |
D/D |
(1,195) |
1,014,313 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
• • – |
2024-02-12 |
4 |
S |
$67.77 |
$77,796 |
D/D |
(1,148) |
1,115,983 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
• • – |
2022-06-17 |
4 |
OE |
$2.67 |
$88,123 |
D/D |
33,005 |
931,280 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
• • – |
2024-05-20 |
4 |
OE |
$3.76 |
$92,120 |
D/D |
24,500 |
1,140,483 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
• • – |
2024-01-16 |
4 |
S |
$66.81 |
$109,032 |
D/D |
(1,632) |
1,121,918 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
• • – |
2023-01-20 |
4 |
D |
$52.05 |
$121,068 |
D/D |
(2,326) |
1,001,088 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
• • – |
2023-11-14 |
4 |
OE |
$3.76 |
$169,200 |
D/D |
45,000 |
1,116,807 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
• • – |
2022-04-29 |
4 |
AS |
$44.43 |
$177,720 |
D/D |
(4,000) |
891,775 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Operating Officer |
• • – |
2020-02-13 |
4 |
OE |
$2.14 |
$250,819 |
D/D |
117,205 |
1,064,079 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Operating Officer |
• • – |
2020-02-12 |
4 |
OE |
$2.14 |
$250,821 |
D/D |
117,206 |
998,949 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Scientific Officer |
• • – |
2024-03-08 |
4 |
OE |
$3.67 |
$253,623 |
D/D |
69,107 |
1,185,090 |
0 |
- |
|
80 Records found
|
|
Page 2 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
